Dr. Harald Hübner

Lehrstuhl für Pharmazeutische Chemie

Abolishing Dopamine D2long/D3Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2Receptor Agonists (2021) Tropmann K, Bresinsky M, Forster L, Mönnich D, Buschauer A, Wittmann HJ, Hübner H, et al. Journal article Radiosynthesis and evaluation of F-18-labeled dopamine D-4-receptor ligands (2021) Willmann M, Ermert J, Prante O, Hübner H, Gmeiner P, Neumaier B Journal article Homobivalent Dopamine D2Receptor Ligands Modulate the Dynamic Equilibrium of D2Monomers and Homo-and Heterodimers (2021) Ullmann T, Gienger M, Budzinski J, Hellmann J, Hübner H, Gmeiner P, Weikert D Journal article Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats (2021) Uzuneser T, Weiss EM, Dahlmanns J, Kalinichenko L, Amato D, Kornhuber J, Alzheimer C, et al. Journal article, Original article Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR (2021) Xu X, Kaindl J, Clark MJ, Hübner H, Hirata K, Sunahara RK, Gmeiner P, et al. Journal article, Original article Fluorescent ligands for dopamine D-2/D-3 receptors (2020) Allikalt A, Purkayastha N, Flad K, Schmidt M, Tabor A, Gmeiner P, Hübner H, Weikert D Journal article, Original article Structure-based development of caged dopamine D2/D3 receptor antagonists (2020) Gienger M, Hübner H, Löber S, König B, Gmeiner P Journal article Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with 18F-Labeled Derivatives in Rats (2020) Ott J, Spilhaug MM, Maschauer S, Rafique W, Jakobsson JE, Hartvig K, Hübner H, et al. Journal article, Original article Structure-based development of a subtype-selective orexin 1 receptor antagonist (2020) Hellmann J, Drabek M, Yin J, Gunera J, Pröll T, Kraus F, Langmead CJ, et al. Journal article Discovery of Novel Nonpeptidic PAR2 Ligands (2020) Klösel I, Schmidt M, Kaindl J, Hübner H, Weikert D, Gmeiner P Journal article